ARTICLE | Clinical News
Novo Nordisk Pharmaceuticals regulatory update
May 15, 1995 7:00 AM UTC
Novo Nordisk Pharmaceuticals The company's Norditropin recombinant human growth hormone received FDA approval to treat children who have growth failure due to inadequate secretion of endogenous grow...